Old Web
English
Sign In
Acemap
>
authorDetail
>
Nandita Joshi Jones
Nandita Joshi Jones
Viloxazine
Attention deficit hyperactivity disorder
Medicine
Anesthesia
Placebo-controlled study
2
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder
2021
Journal of Clinical Psychopharmacology
Azmi Nasser
Tesfaye Liranso
Toyin Adewole
Nicholas Fry
Joseph T. Hull
Gregory D. Busse
Fatima Chowdhry
Andrew J. Cutler
Nandita Joshi Jones
Robert L. Findling
Stefan Schwabe
Show All
Source
Cite
Save
Citations (6)
A Phase III, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Once-Daily SPN-812 (Viloxazine Extended-Release) in the Treatment of Attention-Deficit/Hyperactivity Disorder in School-age Children
2020
Clinical Therapeutics
Azmi Nasser
Tesfaye Liranso
Toyin Adewole
Nicholas Fry
Joseph T. Hull
Fatima A. Chowdhry
Gregory D. Busse
Andrew J. Cutler
Nandita Joshi Jones
Robert L. Findling
Stefan Schwabe
Show All
Source
Cite
Save
Citations (20)
1